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ABSTRACT 
 
Background: The treatment of diseases by use of essential medicines, prescribed by generic names, has 
been emphasized by WHO and National Health Policy of India. Drugs used in gynaecology are one of 
the top selling drugs in India; however they are least studied with respect to drug utilization. Thus 
present study was undertaken to analyze drug utilization pattern of gynecology OPD in a tertiary care 
hospital. Materials and Methods: A retrospective, cross sectional, observational study of prescriptions 
in Gynecology OPD. Data was obtained from an electronic medical record database of patients that 
attended Gynecology OPD during the study period. Prescription records of patients were screened as per 
inclusion and exclusion criteria and 300 prescriptions were randomly selected by Openepi software. 
Patient  related  and  drug  related  information  was  collected  on  a  customized  data  collection  sheet. 
Results: The mean age of patients was 30.19+9.83 years and common age of presentation was >18-30 
years. In infective cases, vaginal discharge (10.33%) was common, and in non-infective cases, menstrual 
disorders (24%) were common. The average number of drugs per prescription was 3.47+1.53. In drug 
category, minerals (30.94%) were most commonly prescribed, followed by antimicrobials (24.98%), and 
NSAIDs (13.37%). Polypharmacy was observed in 96.33% of the prescriptions. Conclusion: It is only 
by drug utilization studies that burden of diseases and corresponding utilization of drugs in gynecology 
can be measured. In our study majority of the drugs prescribed were generic which were from the 
essential medical list NLEM and WHO.  
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INTRODUCTION 
 
Maternal health gives importance because life of 
not only the mother but the child is also at stake. 
There are only a few comprehensive community-
based  studies  in  low  income  countries  that 
quantify burden of gynecological disease in order 
to  influence  health  policy  with  respect  to 
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gynecology.  These  studies  have  shown  a  high 
prevalence of previously unrecognized morbidity 
that places a heavy burden on women.
1,2 
As  per  data  by  All  India  Origin  Chemists  and 
Distributors-Advanced  Working,  Action  & 
Correction  System  (AIOCD-AWACS)  market 
research firm, gynecology drugs are one of the 
strong  selling  drugs  in  pharmaceutical  market; 
they rank as the 8
th in all the super groups with 
16.4% growth in the month of February 2012.
3 
However they are the least studied drugs in terms 
of drug utilization studies.  
The principal aim of drug utilization research is 
to  facilitate  appropriate  use  of  drugs  in patient 
populations,  minimize  the  adverse  event  and 
drug  interactions  leading  to  better  patient 
outcome.
4Considering  the  flow  of  the 
gynecology  patients  and  scarcity  of  data  with 
respect  to  drug  utilization  study  (DUS)  the 
present  study  was  planned  to  examine  the 
patterns of drug prescription in the gynecology 
outpatient  department  (OPD)  of  Government 
Medical  College  and  Hospital,  Aurangabad  a 
biggest  tertiary  care  hospital  covering  eight 
districts of Marathwada Maharashtra state. 
 
MATERIALS AND METHODS   
Study Design : A retrospective, cross sectional, 
observational study. 
Study Duration: 1 year from 01 Dec 2010 – 30 
Nov 2011 
Study  Population:  The  Electronic  Medical 
Record (EMR) data was obtained; consisting of 
prescription  records  of  7762  patients  that 
attended  the  Gynecology  OPD  at  Government 
Medical  College  &  Hospital,  Aurangabad, 
Maharashtra.  
Procedure:  The  study  was  conducted  after 
obtaining  the  permission  from  the  Institutional 
Ethics  Committee,  and  from  the  Local  HMIS 
(hospital  management  information  system) 
project  implementation  committee  of  the 
institute.  All  Ethical  issues  pertaining  to  the 
study  was  taken  into  consideration.  The  7762 
patient’s data was screened and analyzed as per 
the  inclusion  and  exclusion  criteria.  After 
screening  data,  300  patients  were  randomly 
selected  usingOpenepi  software  version  2.3. 
Patient  related  information  like  age,  gender, 
number  of  visits,  diagnosis,  month  of 
presentation,    urban/rural,    drug  related 
information  like  number  of  drugs  prescribed, 
drug  doses,  drug  dosage  form,  route  of 
administration, fixed dose combinations of drugs, 
drugs  prescription  by  generic  or  brand  names 
were  collected  on  a  customized  data  collection 
sheet.  
Inclusion criteria: Data of patients with age >18 
years after screening having details of parameters 
under study were included.  
Exclusion  criteria  for  screening:  Data  of 
Gynecology  In-door  patients  during  the  study 
duration, emergency patients, Incomplete data. 
Parameters  studied  :  The  World  Health 
Organization  (WHO)  indicators  that  were 
selected  to  analyze  the  prescription  pattern 
included.  
1.  Average  number  of  drugs  prescribed  per 
prescription per encounter  
2.  Relationship  between  patient  demographics 
and prescription pattern  
3.  Indications  for  which  various  drugs  were 
prescribed 
4.  Percentage  usage  of  various  drugs,  various 
dosage forms of the drugs  
5. Drugs prescribed by generic name and brand 
name, drugs prescribed from Indian National List 
of Essential Medicine (NLEM) 2011 & WHO list 
of  essential  medicines  2011,  fixed  drug 
combinations and polypharmacy.
5,6 
 
RESULTS 
 
Total  300  gynecology  prescriptions  were 
analyzed.  The  mean  age  of  presentation  was 
30.19 + 9.83 years ranging from >18 to 72 years 
of age. Among all the prescriptions 276 (92%) 
were  from  urban  area  and  24  (8%)  were  from 
rural  area.  The  average  number  of  visits  was 
2.22+1.42.  The  average  number  of  drugs  per 
prescription was 3.49+1.53.  
157  
Baig et al.,     Int J Med Res Health Sci. 2013;2(2):156-163 
Out of 300 patients, 180 (60%), 105 (35%) and 
15  (5%)  patients  were  in  the  age  group  >18-
30,>30-50  and  >50  years  respectively.  85 
(28.33%) were infective cases and 215 (71.67%) 
were non-infective cases. In 31 cases of vaginal 
discharge  28  were  cases  of  white  vaginal 
discharge.  Distribution  of  infective  diseases  is 
given in table1.  
Among non-infective group, menstrual disorders 
were common, in which dysmenorrhea, followed 
by  Dysfunctional  Uterine  Bleeding  (DUB). 
There  were  3  patients  of  Polycystic  Ovarian 
Disease  (PCOD).  In  pelvic  mass  ovarian  cyst 
was  common,  there  were  two  patients  of 
Carcinoma  (Ca)  Cervix  and  one  patient  of 
carcinoma  endometrium.  Distribution  of  non-
infective  gynaecological  diseases  are  given  in 
table  2.  Among  other  diseases  infertility  was 
common;  there  were  13  patients  for  Copper-T 
(Cu-t)  insertion,  4  cases  of  Diabetes  Mellitus 
(DM)  and  3  cases  of  Hypertension  (HTN). 
Distribution of other diseases  given in table 3. 
A  total  of  1047  drugs  was  prescribed.  Out  of 
these  649  (61.99%),  354  (33.81%)  and  44 
(4.20%) were prescribed in >18-30 years, >30-50 
years and >50 years of age group respectively. 
Among all drugs, minerals 324 (30%) were most 
commonly  prescribed.  In  minerals  anti-anemic 
drugs were commonly prescribed 192 (18.33%) 
followed by calcium supplements 132 (12.60%).  
The second most commonly prescribed group of  
drugs  was  antimicrobial  drugs  260(24.83%),  in 
which metronidazole 73 (6.97%) was commonly 
prescribed followed by ciprofloxacin 65 (6.20%) 
and ampicillin 47(4.50%).  
The third group of drugs commonly prescribed 
was  Nonsteroidal  Anti-inflammatory  Drugs 
(NSAIDs) 140 (13.37%), in which ibuprofen 73 
(6.7%)  was  commonly  prescribed  followed  by 
paracetamol  37(3.50%)  and  other  NSAIDs 
(3.17%).  
Others  group  of  drugs  like  antihistamines  119 
(11.37%)  in  which  ranitidine  88  (8.40%)  was 
commonly prescribed followed by cetirizine 22 
(2.10%).  In  hormonal  preparations  40  (3.82%) 
Oral  Contraceptive  Pills  (OCP)  13  (1.2%)  was 
commonly  prescribed  followed  by  cyclical 
progesterone 6 (0.57%). There were 12 (1.15%) 
drugs from Central Nervous System (CNS) class 
and  11  from  cardiovascular  system  (CVS)  and 
DM. Other prescribed drugs classified according 
to pharmacological class are given in Fig 1. Out 
of  1047  drugs  prescribed,  996  (95.13%)  were 
prescribed by generic name, 51 (4.87%) by brand 
name  and  437  (41.73%)  prescribed  were  fixed 
dose  combination.  Among  the  total  drugs 
prescribed 986 (94.17%) were from NLEM and 
880  (84.05%)  were prescribed  from  WHO  list. 
Polypharmacy  (containing  >2  drugs  per 
prescriptions)  was  observed  in  289  (96.33%) 
prescriptions. Distribution of drugs according to 
various dosage forms is given in table IV. 
 
Table 1: Distribution of infective diseases according to age. 
Infective Diseases  Number of patients 
Age>18-30 yrs  Age >30-50yrs  Age >50 yrs  Total  Percentage* 
Vaginal discharge  15  11  5  31  10.33 
PID  14  6  0  20  6.67 
UTI  4  6  0  10  3.33 
Abscess  5  2  0  7  2.33 
Episiotomy wound  3  0  0  3  1.00 
Cough fever  4  0  0  4  1.33 
Diarrhea  2  1  0  3  1.00 
TineaCorporis  3  1  0  4  1.33 
Scabies  2  0  0  2  0.67 
Tuberculosis  1  0  0  1  0.33 
TOTAL  53  27  5  85  28.33 
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Table 2: Distribution of non-infective gynaecological diseases according to age. 
Non infective Diseases  Age in years (Number of patients) 
Age 
>18-30 yrs 
Age 
>30-50 yrs 
Age 
>50 yrs 
Total  Percentage* 
Menstrual Disorders           
Dysmenorrhea  19  12  2  33  11.00 
DUB  4  11  1  16  4.33 
Menorrhagia  6  6  1  13  5.33 
Bleeding per vaginum  2  2  0  4  1.33 
PCOD  3  0  0  3  1.00 
Irregular menses  2  0  0  2  0.67 
Amenorrhea  1  0  0  1  0.33 
Pelvic Mass           
Ovarian cyst  5  9  0  14  4.67 
Fibroid uterus  2  5  0  7  2.33 
Prolapse  0  3  4  7  2.33 
Adenomyosis  0  2  0  2  0.67 
Ca Cervix  0  1  1  2  0.67 
Ca Endometrium  0  0  1  1  0.33 
Fibroadenosis  1  0  0  1  0.33 
Vesicular mole  0  1  0  1  0.33 
TOTAL  45  52  10  107  35.65 
 
Table 3: Distribution of other diseases according to age. 
Other Diseases  Age in years (Number of patients) 
Age 
>18-30 yrs 
Age 
>30-50 yrs 
Age 
>50 yrs 
Total  Percentage* 
Post Natal Cases  30  4  0  34  11.33 
Postpartum psychosis  3  0  0  3  1.00 
Cu-t  11  2  0  13  4.33 
Lump in breast  3  0  0  3  1.00 
Anemia  7  2  0  9  3.00 
Backache  1  3  0  4  1.33 
Headache  2  0  0  2  0.67 
Hypothyroid  1  1  0  2  0.67 
Diabetes mellitus 
(DM) 
0  2  2  4  1.33 
Hypertension (HTN)  1  2  0  3  1.00 
TOTAL  88  18  2  108  35.99 
*Note: In table 1-3, percentages are out of 300. 
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Table 4: Distribution of drugs according to various dosage forms. 
Sr.No  Dosage forms  Total (Drugs)  Percentage (%) 
1  Tablet  854  81.57 
2  Capsule  135  12.90 
3  Pessary  27  2.58 
4  Topical   15  1.43 
5  Injection  9  0.86 
6  Syrup  7  0.67 
  TOTAL  1047  100 
 
 
#Percentage calculated out of 1047 
Fig. 1: Distribution of drugs according to pharmacological class. 
DISCUSSION 
 
The  data  in  our  study  were  accessed  by  EMR 
managed  by  the  Hospital  Management 
information  system.  It  has  several  advantages 
like data safety, reduced prescription errors and 
easy retrieval at one-click for records analysis. 
7 
In  our  study  mean  age  of  presentation  was 
30.19+9.83  years  and  the  most  common  age 
group was >18-30 years. In studies carried out by 
Kaur  et  al  mean  age  of  women  attending 
Gynecology  OPD  was  29.80  ±  6.293 
years.
8Similarly,    Shalini  et  al  reported  70% 
patients were between 20-29 years.
9 In our study 
92%  patients  were  from  urban  areas  and  8% 
were from rural area. This indicates that majority 
of  the  rural  patients  depend  on  the  peripheral 
health services for gynecologicaldiseases. 
Reproductive/Sexual  tract  infections  (RTI/STI) 
are  major  cause  of  gynecological morbidity  all 
over the world.
9NFHS–3, estimates that 11.1% of 
women  were  reported  to  have  STI  in  India. 
10Thapa et al reported that commonest age group 
of  STI  is  20-29  years  and  the  most  common 
symptoms are vaginal discharge. 
11 According to 
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Patel et al, Pelvic Inflammatory Disease (PID) is 
one  of  the  most  serious  infections  and  is  a 
common problem encountered in gynecological 
clinics  in  India  and  abroad. 
12  In  our  study 
urinary tract infection (UTI) was seen in >30-50 
years of age group. As per Gupta et al, more than 
half  of  the  females  with  lower  urinary  tract 
symptoms were middle aged between 31-55years 
of age.
13 
Among menstrual disorders in our study in>18-
30  years  of  age  group  dysmenorrhea  was 
common.  As  per  Harlow  et  al  menstrual 
disturbances  are  between  first  and  fourth  most 
common  reported  gynecological  complaints  in 
India.
14  
According  to  Adamson  et  al  infertility  varies 
across regions of the world and is estimated to 
affect 8 to 12 per cent of couples worldwide. 
15 
There were 10.33% cases of infertility, 4 patients 
of ovarian cyst, 7 fibroid uterus and 7 of prolapse 
in  our  study.  The  results  of  our  study  are 
consistent with Walraven et al, 
1Shalini et al, 
9 
and Bhatia et al
16with regards to distribution of 
gynecological  diseases.  The  distribution  of 
gynecological  diseases  in  our  study  correlates 
with the distribution in other studies. This study 
has  shown  the  distribution  of  the  majority  of 
gynaecological  diseases  across  various  age 
groups which very few studies have reported. 
Among  all  the  drugs,  30%  prescribed  were 
minerals  in  which  anti-anemic  drugs  were 
commonly  prescribed.  In  India  55%  of  the 
females  have  anemia  and  is  more  widespread 
among both women and children and it has risen 
almost 5% points than NFHS-2.
17 As per Bhatia 
et  al  approximately  one-third  of  all  women  in 
OPD  reported  symptoms  of  anemia.
18  In  our 
study  diagnosed  cases  of  anemia  was  less 
compared  to  anti-anemic  drugs  prescribed  as 
majority  of  anti-anemic  drugs  prescribed  were 
based on symptoms of anemia. 
The second commonly prescribed group in our 
study  was  antimicrobial  drugs,  in  which 
metronidazole  was  common  followed  by 
ciprofloxacin and ampicillin. In a study by Shah 
et  al  in  indoor  patients  ciprofloxacin  (60.90%) 
was  commonly  used  followed  by  ampicillin 
(54.54%)  and  metronidazole  (39.69%).    A 
number of Indian studies have recorded a high 
level  of  use  of  ampicillin,  metronidazole, 
ciprofloxacin,  gentamicin,  cefazolin  in 
gynecological department.
19 As per Sihavong et 
al,  recommended  drugs  for  the  treatment  of 
vaginal  discharge  and  lower  abdominal  pain 
syndromes  include  metronidazole  orally  or 
vaginal  suppository.
20,21  Metronidazole  is 
effective  for  the  management  of  anaerobic 
infections,  such  as  intra-abdominal  infections, 
gynecologic  infections  and  for  mixed,  aerobic 
and anaerobic infection.
22 As metronidazole was 
commonly  prescribed  for  anaerobic  infections 
ingynecological diseases along with combination 
with  other  antimicrobial  agents,  metronidazole 
topped list of antimicrobial drugs in our study. 
The  third  commonly  prescribed  drugs  in  our 
study was NSAIDs. As per Dhaubhadel et al pain 
is  the  most  distressing  experience  of  human 
beings  and  pelvic  pain  is  one  of  the  most 
common reasons for gynecology consultation. 
23    
The average number of drugs per prescription in 
our study was 3.49+1.53. It is recommended to 
limit  the  number  of  drugs  prescribed  per 
prescription  should  be  2,  because  of  increased 
risk  of  drug  interactions.
24 Around  40%  of  the 
women  have  STI  at  a  given  point  in  time  and 
only  1%  completes  full  treatment  of  both  the 
partners.
20  Due  to  unawareness  of  the 
gynecological  diseases  there  is  less  follow-up 
which is a contributing factor for the increase in 
drugs per prescription.  
The  drugs  utilized in  our  study  correlates  with 
the  pattern  of  various  gynecological  diseases 
observed  in  our  study,  however  there  were  no 
DUS  that  shows  the  utilization  of  minerals, 
hormones,  NSAIDs  and  antihistamines  which 
were  the  other  commonly  used  drugs  in  our 
study.In  our  study  majority  of  the  drugs 
prescribed  were  generic  which  were  from  the 
essential medical list NLEM and WHO.  
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CONCLUSION 
 
Our  study  focused  on  understanding  drug 
prescription and prescription trends with respect 
to Gynecology OPD. It is only by drug utilization 
studies that burden of diseases and corresponding 
utilization  of  drugs  in  gynecology  can  be 
measured.  
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